Abstracts submission will open on 15 May 2017.


The Scientific Committee welcomes the submission of abstracts for original research papers for presentation during the ESCCA 2017 conference.

 

Key dates
15 May   Abstract submission open 
30 June   Deadline abstract submission (23:59:59 CEST)  
On or around 14 July      Notifications of acceptance 
31 July Early registration deadline
7 August Deadline for registration and payment for all abstract presenters

 

Topics

Oral presentations:

  • Flow cytometry in clinical trials
  • Hematological cell populations
  • Immunological cell populations
  • New capabilities for flow cytometry
  • Quality control
  • Other

Poster presentations:

  • Advances in Cytometry
  • Hematology-Oncology
  • Immunology
  • Other

 

Presentation categories

Accepted papers will be divided into two categories:

  • Oral presentations of 10-15 minutes including discussion time 
  • Poster presentations with a poster displayed in the exhibition area. 

 

Best poster abstract presentations

The 6 best poster abstracts will be selected for a short oral presentation of 7 minutes in Plenary Session 6 on Tuesday 25 September. In order to qualify, presenting authors should have submitted their abstract  before the submission deadline of 30 June and should be registered for the conference before 15 July.

 

Awards 

The 3 best oral abstracts will be selected for presentation in the plenary Best Oral Presentations session on Wednesday (PLE-9). One of the presenters will be selected for the ESCCA Best Oral Award. In order to qualify, presenting authors should have submitted their abstract  before the submission deadline of 30 June and should be registered for the conference before 14 July.

The the ESCCA Best Poster Award the best poster will be selected on-site by the Scientific Committee.

The winners will be announced in the above mentioned session and will be awarded with to a free registration for the 2018 Conference.


Abstract preparation instructions

Abstracts can only be submitted online. Submissions by fax, post or email will not be considered.

All abstracts must be written in English.

It is the author’s responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific fact in the abstract text will be reproduced as typed by the author. Abstract titles will be subject to a spell check if the abstract is selected for presentation.

Authors may submit a maximum of two abstracts as leading author but can be mentioned as a co-author of other papers.

 

Size

Maximum length of the abstract: 400 words. Longer abstracts will not be uploadable! The submission programme will automatically calculate the size of your abstract and will not allow submissions that do not fit the size requirements.

 

Title

Maximum length of the title: 20 words. Please make sure to type the title correctly. Do NOT type the full title in capital letters. Do NOT put a full stop after the title. The title should clearly define the topic. Do NOT identify your institution in the title.

Example 1: Guidelines on clinical diagnostic cytometry

Example 2: Diagnosis in immunodeficiencies. A summary

 

Body of the abstract

Abstracts in all categories and without exception should be written and structured as indicated below. Single line spacing required. 

The 4 paragraph headers should be in bold and followed by a colon (:), a space, and then the text. As follows:

Introduction: Indicate the purpose and objective of the research, the hypothesis that was tested or a description of the problem being analysed or evaluated.
Methods: Describe the setting/location for the study, study design, study population, ethical considerations, data collection and methods of analysis used.
Results: Present as clearly and detailed as possible the findings/outcome of the study, with specific results in summarised form.
Conclusions: Briefly discuss the data and main outcome of the study, treatment, care and/or support, and implications of the results. (it is not acceptable to state: “The results will be discussed”).

 

Important!

  • NO white lines between the text and the headers.
  • Images or pictures are NOT allowed.
  • Use numbers for numbers and only very well-known abbreviations e.g., ml, kg, MRI. If you must use other abbreviations, you must explain the first time it appears.
  • Maximum number of words: 400

 


Submit your abstract HERE (link available on 15 May)

Follow the instructions mentioned in the online abstract submission system. You will receive an email to confirm that your abstract has been submitted succesfully.

Please note: All presenters of accepted abstracts must register to attend the ESCCA 2017 Conference before 7 August.

In line with the ESCCA policy, a honorarium or expense payment will not be provided for the presenters.


Questions?

Global Conference Support has assigned Parthen to process the registrations and abstracts for this conference. Please contact them directly if you need assitance with the abstract submission process:
Parthen
Amsterdam, the Netherlands
e-mail: registration@parthen.nl
phone: +31 20 572 73 01


Copyright

Copyright of the abstract(s) is assigned to ESCCA and/or the ESCCA 2017 Conference. Accepted abstracts can be published in one of the following publications:

  • Online abstract book downloadable from the Conference website (access restricted to registered participants only, for the duration of 1 month)*
  • Online abstract book published on the ESCCA website / membership section (no time restriction)
  • Online publication at the Cytometry B website

* During that time each individual abstract will also be available for viewing and downloading via the online scientific programme.

 

Terms of use

By accessing and/or using the online submission system you agree (also on behalf of co-authors) to all the terms of the abstract submission guidelines and instructions as mentioned on this webpage. Please note that transfer of copyright applies to all material submitted through this online system.

 

Conference Embargo Policy

In the case of the ESCCA 2017 Conference, as with most scientific/medical conferences, all conference abstracts are released to delegates under a strict embargo policy. You will acknowledge that it is a condition of your acceptance that you will not provide another lecture/workshop/seminar to an audience in Europe for a period of two weeks before or after the conference, apart from regular undergraduate and/or postgraduate teaching.


Abstract review,  selection and notifications 

 

Abstract review

All submitted abstracts will go through a blind peer-review carried out by an international reviewing committee.
Reviewers will give rankings from 1 to 5 points, taking into consideration the following 4 criteria:

  • Relevance of the subject/originality
  • Relevance/value of the results
  • Study design/scientific value
  • Quality of presentation

After giving the rankings, reviewers will submit the recommended presentation style (oral or poster). Reviewers can make suggestions to the subject.

 

Abstract selection

The Scientific Committee makes the final selection of abstracts to be included in the conference programme. The highest-scoring abstracts are selected for an oral presentation in the parallel sessions. Abstracts selected for presentation as a poster will be on display during the whole conference.

 

Notification of Acceptance or Rejection to Corresponding Author

Notification of acceptance or rejection will be sent to the submitting (corresponding) author. Please note that only the corresponding author will receive mail concerning the abstract and is responsible for informing all co-authors of the status of the abstract. Authors whose abstracts have been accepted will receive instructions for the presentation of their abstract.